PT1223914E - Composicao de desintegracao oral que compreende mirtazapina - Google Patents

Composicao de desintegracao oral que compreende mirtazapina

Info

Publication number
PT1223914E
PT1223914E PT00971346T PT00971346T PT1223914E PT 1223914 E PT1223914 E PT 1223914E PT 00971346 T PT00971346 T PT 00971346T PT 00971346 T PT00971346 T PT 00971346T PT 1223914 E PT1223914 E PT 1223914E
Authority
PT
Portugal
Prior art keywords
mirtazapine
understands
oral disintegration
disintegration composition
composition
Prior art date
Application number
PT00971346T
Other languages
English (en)
Portuguese (pt)
Inventor
Henrik De Nijs
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240737&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1223914(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT1223914E publication Critical patent/PT1223914E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT00971346T 1999-10-13 2000-10-09 Composicao de desintegracao oral que compreende mirtazapina PT1223914E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203338 1999-10-13
PCT/EP2000/009863 WO2001026621A2 (en) 1999-10-13 2000-10-09 Orally distintegrating composition comprising mirtazapine

Publications (1)

Publication Number Publication Date
PT1223914E true PT1223914E (pt) 2004-11-30

Family

ID=8240737

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00971346T PT1223914E (pt) 1999-10-13 2000-10-09 Composicao de desintegracao oral que compreende mirtazapina

Country Status (28)

Country Link
EP (1) EP1223914B1 (pl)
JP (1) JP5561885B2 (pl)
KR (1) KR100708560B1 (pl)
CN (1) CN1173701C (pl)
AR (1) AR026010A1 (pl)
AT (1) ATE274899T1 (pl)
AU (1) AU780379B2 (pl)
BR (1) BR0014593A (pl)
CA (1) CA2386547C (pl)
CO (1) CO5251412A1 (pl)
CZ (1) CZ20021315A3 (pl)
DE (2) DE60013466T2 (pl)
ES (1) ES2194618T3 (pl)
HK (1) HK1046641B (pl)
HU (1) HUP0203148A3 (pl)
IL (2) IL148777A0 (pl)
MX (1) MXPA02003519A (pl)
NO (1) NO20021730L (pl)
NZ (1) NZ518165A (pl)
PE (1) PE20010699A1 (pl)
PL (1) PL200858B1 (pl)
PT (1) PT1223914E (pl)
RU (1) RU2261098C2 (pl)
SK (1) SK6452002A3 (pl)
TR (1) TR200200978T2 (pl)
TW (1) TWI256309B (pl)
WO (1) WO2001026621A2 (pl)
ZA (1) ZA200202293B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
CA2643802A1 (en) * 2006-02-27 2007-09-07 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CN101129341B (zh) * 2006-08-22 2011-06-01 上海医药工业研究院 口内崩解组合物及其制备方法
EP2377522B1 (en) 2010-04-15 2013-01-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
CN102993208B (zh) * 2011-11-22 2017-01-18 北京哈三联科技股份有限公司 去甲肾上腺素和选择性五羟色胺受体阻断剂及其应用
EP2819653B1 (en) * 2012-03-02 2017-01-11 Rhodes Pharmaceuticals L.P. Tamper resistant immediate release formulations
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
JP6601844B2 (ja) * 2016-12-05 2019-11-06 共和薬品工業株式会社 光安定性に優れたミルタザピン含有医薬製剤
CN111714463B (zh) * 2020-08-14 2022-06-17 华农（肇庆）生物产业技术研究院有限公司 米氮平口服剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
WO1991004757A1 (en) * 1989-10-02 1991-04-18 Cima Labs, Inc. Effervescent dosage form and method of administering same
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
JP3168695B2 (ja) * 1991-06-14 2001-05-21 三菱化学株式会社 ショ糖脂肪酸エステルの置換度の低下方法
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JPH05163137A (ja) * 1991-12-12 1993-06-29 Shin Etsu Chem Co Ltd 有核顆粒
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
JPH0737473A (ja) * 1993-07-27 1995-02-07 Murata Mfg Co Ltd 圧力スイッチ
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
JP3870470B2 (ja) * 1997-02-07 2007-01-17 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤

Also Published As

Publication number Publication date
JP5561885B2 (ja) 2014-07-30
CN1378452A (zh) 2002-11-06
PL200858B1 (pl) 2009-02-27
CO5251412A1 (es) 2003-02-28
MXPA02003519A (es) 2002-08-20
JP2003511403A (ja) 2003-03-25
RU2261098C2 (ru) 2005-09-27
EP1223914A2 (en) 2002-07-24
BR0014593A (pt) 2002-06-11
CN1173701C (zh) 2004-11-03
DE60013466T2 (de) 2005-01-20
PL354584A1 (pl) 2004-01-26
DE60013466D1 (de) 2004-10-07
CZ20021315A3 (cs) 2002-07-17
IL148777A (en) 2013-10-31
ES2194618T3 (es) 2005-04-01
SK6452002A3 (en) 2002-09-10
ES2194618T1 (es) 2003-12-01
AU1023201A (en) 2001-04-23
IL148777A0 (en) 2002-09-12
NZ518165A (en) 2004-03-26
KR100708560B1 (ko) 2007-04-19
CA2386547C (en) 2010-06-08
ATE274899T1 (de) 2004-09-15
NO20021730L (no) 2002-05-30
PE20010699A1 (es) 2001-07-06
AR026010A1 (es) 2002-12-26
EP1223914B1 (en) 2004-09-01
ZA200202293B (en) 2003-06-20
NO20021730D0 (no) 2002-04-12
HK1046641A1 (en) 2003-01-24
WO2001026621A3 (en) 2001-10-11
CA2386547A1 (en) 2001-04-19
RU2002112238A (ru) 2004-01-10
TR200200978T2 (tr) 2002-09-23
KR20020038946A (ko) 2002-05-24
HUP0203148A2 (hu) 2003-01-28
DE1223914T1 (de) 2003-09-18
TWI256309B (en) 2006-06-11
AU780379B2 (en) 2005-03-17
HUP0203148A3 (en) 2004-06-28
WO2001026621A2 (en) 2001-04-19
HK1046641B (zh) 2005-04-08

Similar Documents

Publication Publication Date Title
DE60143252D1 (de) Dentalklebstoffzusammensetzung
DE60135302D1 (de) Aushärtbare dentalzusammensetzung
DE60014511D1 (de) Zahnärztliche Haftmittelzusammensetzung
DE60031024D1 (de) Fluorkautschukzusammensetzungen
DE60028268D1 (de) Fluorkautschukzusammensetzungen
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
IS6120A (is) Lyfjablanda
PT1242087E (pt) Composicoes farmaceuticas
AR023440A1 (es) Composiciones antitranspirantes
DE60013221D1 (de) Fotopolymerisierbare Zusammensetzung
AR028320A1 (es) Nuevas composiciones de antihelminticos
DK1524266T3 (da) Farmaceutisk sammensætning
ITMI20010748A0 (it) Composizioni farmaceutiche
ID29785A (id) Komposisi-komposisi sampo
DE60007731D1 (de) Schweisshemmende zusammensetzungen
NO20026123L (no) Farmasöytiske sammensetninger
NO20014834D0 (no) Tannprotese adhesive sammensetninger
DE69943245D1 (de) Gaserzeugende zusammensetzung
PT1239832E (pt) Composicoes farmaceuticas
PT1223914E (pt) Composicao de desintegracao oral que compreende mirtazapina
NO20031095D0 (no) Farmasöytiske sammensetninger
DE50014354D1 (de) Dentalwerkzeug
DE60008839D1 (de) Duftstoff-Zusammensetzung
FI4488U1 (fi) Farmaseuttinen koostumus